Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBW 2992; Drug: Investigator´s choice of chemotherapy
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: linagliptin; Drug: placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: PT003 MDI; Drug: PT005 MDI; Drug: Placebo MDI; Drug: Tiotropium bromide 18 μg (Spiriva Handihaler®); Drug: Formoterol Fumarate 12 μg (Foradil® Aerolizer®); Drug: PT001 MDI
Sponsor: Pearl Therapeutics, Inc.
Recruiting - verified March 2010
Condition: Cardiovascular Disease
Interventions: Drug: Active Clonidine; Drug: Placebo Clonidine; Drug: Active ASA; Drug: Placebo ASA
Sponsor: Hamilton Health Sciences
Not yet recruiting - verified March 2010
Conditions: Chronic Medical Conditions; Personal Health Records; Electronic Medical Record
Interventions: Device: Electronic (USB) Portable Health File; Device: Paper Portable Health File
Sponsors: St George Hospital, Australia; South Eastern Area Health Service; The University of New South Wales; National Health and Medical Research Council, Australia
Not yet recruiting - verified March 2009
Conditions: Advanced Gastric Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: AUY922; Drug: Docetaxel or Irinotecan
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified March 2010
Conditions: Ovarian; Breast; Prostate; Pancreatic; Advanced Tumours
Intervention: Drug: olaparib
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Hepatocellular Cancer
Intervention:
Sponsor: Sydney West Area Health Service
Recruiting - verified February 2010
Condition: Ovarian Cancer
Interventions: Drug: olaparib; Drug: paclitaxel; Drug: carboplatin
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Patients Who Participated in an Intravitreal Brimo PS DDS® Study
Intervention: Drug: intravitreal brimonidine tartrate implant using Posterior Segment Drug Delivery System (PS DDS®) Applicator
Sponsor: Allergan
Recruiting - verified February 2010
Conditions: Metabolic Syndrome; Hypercholesterolemia
Intervention: Drug: Metformin
Sponsor: Sydney West Area Health Service
Recruiting - verified February 2010
Conditions: Breast Cancer; CYP2D6 Polymorphism
Intervention: Drug: Tamoxifen
Sponsor: Sydney West Area Health Service
Not yet recruiting - verified February 2010
Conditions: Arrhythmia; Heart Failure
Intervention:
Sponsor: Medtronic Cardiac Rhythm Disease Management
Recruiting - verified February 2010
Conditions: Arrhythmia; Bradycardia
Intervention:
Sponsor: Medtronic Cardiac Rhythm Disease Management
Recruiting - verified February 2010
Conditions: Arrhythmia; Heart Failure
Intervention:
Sponsor: Medtronic Cardiac Rhythm Disease Management
Recruiting - verified February 2010
Condition: Intubation, Gastrointestinal
Interventions: Drug: Lignocaine; Drug: Placebo
Sponsor: Queensland Children's Medical Research Institute
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Not yet recruiting - verified February 2010
Condition: Endometrial Cancer
Intervention:
Sponsors: Queensland Centre for Gynaecological Cancer; Greenslopes Private Hospital; University of Queensland; Sullivan and Nicolaides Pathology
Recruiting - verified February 2010
Condition: Acute Myeloid Leukemia
Interventions: Drug: A: Azacitidine (Vidaza); Drug: B: Conventional Care Regimen
Sponsor: Celgene Corporation
Not yet recruiting - verified February 2010
Conditions: Diabetes Mellitus Type 2; Impaired Glucose Tolerance
Interventions: Drug: canakinumab + background diabetes therapy; Drug: placebo + background diabetes therapy
Sponsor: Novartis
Recruiting - verified February 2010
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
